Delivery of Itraconazole from Extruded HPC Films
暂无分享,去创建一个
Michael A Repka | Stacy M. Trey | M. Repka | D. Wicks | Praveen K Mididoddi | P. Mididoddi | Stacy M Trey | Douglas A Wicks | Praveen K. Mididoddi
[1] G. Cleary. Transdermal Delivery Systems: A Medical Rationale , 1993 .
[2] D. L. Massart,et al. Itraconazole Formulation Studies of the Melt-Extrusion Process with Mixture Design , 2003, Drug development and industrial pharmacy.
[3] Geert Verreck,et al. Increased physical stability and improved dissolution properties of itraconazole, a class II drug, by solid dispersions that combine fast- and slow-dissolving polymers. , 2004, Journal of pharmaceutical sciences.
[4] K. Chowdary,et al. Investigation of Dissolution Enhancement of Itraconazole by Solid Dispersion in Superdisintegrants , 2000, Drug development and industrial pharmacy.
[5] R. Summerbell,et al. Prevalence and epidemiology of toenail onychomycosis in diabetic subjects: a multicentre survey , 1998, The British journal of dermatology.
[6] S. Murdan. Drug delivery to the nail following topical application. , 2002, International journal of pharmaceutics.
[7] B. Elewski,et al. A large-scale North American study of fungal isolates from nails: the frequency of onychomycosis, fungal distribution, and antifungal susceptibility patterns. , 2000, Journal of the American Academy of Dermatology.
[8] M. Repka,et al. Influence of human nail etching for the assessment of topical onychomycosis therapies. , 2004, International journal of pharmaceutics.